Lensiprazine

CAS No. 327026-93-7

Lensiprazine( —— )

Catalog No. M34638 CAS No. 327026-93-7

Lensiprazine (SLV314) is a potent dopamine D(2) receptor antagonist that acts as a serotonin reuptake inhibitor , and can be used to study bipolar disorder and schizophrenia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 192 In Stock
10MG 274 In Stock
25MG 430 In Stock
50MG 600 In Stock
100MG 820 In Stock
200MG 1097 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Lensiprazine
  • Note
    Research use only, not for human use.
  • Brief Description
    Lensiprazine (SLV314) is a potent dopamine D(2) receptor antagonist that acts as a serotonin reuptake inhibitor , and can be used to study bipolar disorder and schizophrenia.
  • Description
    Lensiprazine (SLV314) is a potent dopamine D(2) receptor antagonist that acts as a serotonin reuptake inhibitor , and can be used to study bipolar disorder and schizophrenia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Dopamine Receptor | 5-HT Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    327026-93-7
  • Formula Weight
    422.5
  • Molecular Formula
    C24H27FN4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@H]1OC2=C(C=CC=C2NC1=O)N3CCN(CCCC=4C=5C(NC4)=CC=C(F)C5)CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • N-0500 HCl

    N-0500 HCl is a very potent centrally acting DA receptor agonist. N-0500 HCl is a potent displacer of the specific [3H]DP_x005f5,6-ADTN binding with IC50 of 3nM.

  • Phenothiazine

    Phenothiazine is a dopamine-2 (D2) receptor antagonist therefore decreases the effect of dopamine in the brain.

  • NMI 8739

    NMI 8739 is an agonist of D2 autoreceptor. NMI 8739 reduces NO production and elicits concentration-dependent suppression of CCL-20, MCP-1 and IL-6 release.